502 related articles for article (PubMed ID: 16859832)
1. Mediators of PGE2 synthesis and signalling downstream of COX-2 represent potential targets for the prevention/treatment of colorectal cancer.
Chell S; Kaidi A; Williams AC; Paraskeva C
Biochim Biophys Acta; 2006 Aug; 1766(1):104-19. PubMed ID: 16859832
[TBL] [Abstract][Full Text] [Related]
2. Prospects in NSAID-derived chemoprevention of colorectal cancer.
Chell S; Patsos HA; Qualtrough D; H-Zadeh AM; Hicks DJ; Kaidi A; Witherden IR; Williams AC; Paraskeva C
Biochem Soc Trans; 2005 Aug; 33(Pt 4):667-71. PubMed ID: 16042570
[TBL] [Abstract][Full Text] [Related]
3. Use of NSAIDs for the chemoprevention of colorectal cancer.
Herendeen JM; Lindley C
Ann Pharmacother; 2003 Nov; 37(11):1664-74. PubMed ID: 14565811
[TBL] [Abstract][Full Text] [Related]
4. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2.
Gupta RA; Dubois RN
Nat Rev Cancer; 2001 Oct; 1(1):11-21. PubMed ID: 11900248
[TBL] [Abstract][Full Text] [Related]
5. Role of cyclooxygenase-2 in pathogenesis and prevention of colorectal cancer.
Hahn E; Kraus S; Arber N
Dig Dis; 2010; 28(4-5):585-9. PubMed ID: 21088406
[TBL] [Abstract][Full Text] [Related]
6. Chemoprevention of colorectal cancer: ready for routine use?
Arber N; Levin B
Recent Results Cancer Res; 2005; 166():213-30. PubMed ID: 15648192
[TBL] [Abstract][Full Text] [Related]
7. Dual acting anti-inflammatory drugs: a reappraisal.
Bertolini A; Ottani A; Sandrini M
Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
[TBL] [Abstract][Full Text] [Related]
8. Prevention of colorectal cancer using COX-2 inhibitors: basic science and clinical applications.
Chu AJ; Chou TH; Chen BD
Front Biosci; 2004 Sep; 9():2697-713. PubMed ID: 15353307
[TBL] [Abstract][Full Text] [Related]
9. An introduction to aspirin, NSAids, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part II.
Moyad MA
Semin Urol Oncol; 2001 Nov; 19(4):306-16. PubMed ID: 11769882
[TBL] [Abstract][Full Text] [Related]
10. COX-2: a molecular target for colorectal cancer prevention.
Brown JR; DuBois RN
J Clin Oncol; 2005 Apr; 23(12):2840-55. PubMed ID: 15837998
[TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase-2 as a target for prevention of colorectal cancer.
Bertagnolli MM
Curr Oncol Rep; 1999; 1(2):173-8. PubMed ID: 11122816
[TBL] [Abstract][Full Text] [Related]
12. COX-2, NSAIDs and human neoplasia. Part I: Colorectal neoplasms.
Nasir A; Fernandez PM; Chughtai OR; Kaiser HE
In Vivo; 2002; 16(6):501-9. PubMed ID: 12494894
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2 inhibition prevents colorectal cancer: from the bench to the bed side.
Samoha S; Arber N
Oncology; 2005; 69 Suppl 1():33-7. PubMed ID: 16210875
[TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase as a target for colorectal cancer chemoprevention.
Moreira L; Castells A
Curr Drug Targets; 2011 Dec; 12(13):1888-94. PubMed ID: 21158711
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandins and cancer.
Wang D; Dubois RN
Gut; 2006 Jan; 55(1):115-22. PubMed ID: 16118353
[TBL] [Abstract][Full Text] [Related]
16. [Cyclooxygenase(COX)-2-inhibition in the prevention and treatment of colorectal carcinoma].
Tuynman JB; Hulscher JB; Steller EP; van Lanschot JJ; Richel DJ
Ned Tijdschr Geneeskd; 2003 Nov; 147(45):2207-12. PubMed ID: 14640057
[TBL] [Abstract][Full Text] [Related]
17. Chemoprevention strategies using NSAIDs and COX-2 inhibitors.
Keller JJ; Giardiello FM
Cancer Biol Ther; 2003; 2(4 Suppl 1):S140-9. PubMed ID: 14508092
[TBL] [Abstract][Full Text] [Related]
18. Chemoprevention of colorectal cancer: ready for routine use?
Arber N; Levin B
Curr Top Med Chem; 2005; 5(5):517-25. PubMed ID: 15974946
[TBL] [Abstract][Full Text] [Related]
19. Targeting cyclooxygenase-2 for prevention and therapy of colorectal cancer.
Sinicrope FA
Mol Carcinog; 2006 Jun; 45(6):447-54. PubMed ID: 16688727
[TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase as a target for chemoprevention in colorectal cancer: lost cause or a concept coming of age?
Doherty GA; Murray FE
Expert Opin Ther Targets; 2009 Feb; 13(2):209-18. PubMed ID: 19236238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
